Conservative treatment for patent ductus arteriosus in the preterm
- PMID: 17213270
- PMCID: PMC2675417
- DOI: 10.1136/adc.2006.104596
Conservative treatment for patent ductus arteriosus in the preterm
Abstract
Background: A patent ductus arteriosus (PDA) is common among preterms, and prophylactic medical treatment has been advocated as the first-line approach. Conservative treatment may result in similar outcome, but without exposure to the harmful side effects of medication. A retrospective analysis revealed a ductal closure rate of 94% after conservative treatment with adjustment of ventilation (lowering the inspiratory time and increasing positive end expiratory pressure) and fluid restriction.
Objective: To study prospectively over one year the rate of PDA closure, and morbidity and mortality following conservative treatment.
Method: Prospective study (1 January 2005 - 31 December 2005) including 30 newborns <or=30 weeks' gestation, all of whom were being ventilated and required surfactant. Echocardiography was performed 48-72 h after birth. Clinically important PDA was conservatively treated as described above. The percentage of children with PDA, ductal ligation and major complications was determined.
Results: Ten neonates (33%) developed a clinical important PDA. Following conservative treatment the duct closed in all neonates (100%), and none required ductal ligation or medical treatment. The rates of major complications were no higher than those reported by the Vermont Oxford Network and in the literature.
Conclusion: The managed care plan resulted in an overall ductal closure rate of 100%. These results suggest that conservative treatment of PDA is a worthy alternative to prophylactic medical treatment.
Conflict of interest statement
Competing interests: None.
References
-
- Wyllie J. Treatment of patent ductus arteriosus. Semin Neonatol 20038425–432. - PubMed
-
- Malviya M, Ohlsson A, Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 20033CD003951 - PubMed
-
- Flores M. Ibuprofen: alternative treatment for patent ductus arteriosus. Neonatal Netw 20032227–31. - PubMed
-
- Knight D B. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 2001663–73. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical